logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rachel N. Grisham

Memorial Sloan Kettering Cancer Center
H指数:32
被引数:4,988

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201

奥拉帕尼联合达芬钦在复发性低级别浆液性卵巢癌中的长期疗效与安全性：ENGOT-OV60/GOG-3052/RAMP 201研究2年随访结果

Gynecologic Oncology
IF4.1
2026-09-010
OAAI
Grisham, Rachel N.; Van Nieuwenhuysen, Els; Santin, Alessandro D.; D'Hondt, Veronique; Thaker, Premal H.; Clamp, Andrew R.; Moore, Kathleen N.; Aghajanian, Carol; Oaknin, Ana; O'Malley, David M.; Monk, Bradley J.; Colombo, Nicoletta; Prendergast, Emily N.; Ring, Kari L.; Ray-Coquard, Isabelle; Rose, Peter G.; Gourley, Charlie; Holloway, Robert W.; Chon, Hye Sook; Van Gorp, Toon; Youssou, Hagop; Salinas, Erin; Lustgarten, Stephanie; Banerjee, Susana N.
Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer

卵巢癌中mirvetuximab soravtansine-gynx引起的白内障发生率及临床特征：一种未被充分认识的副作用

International Journal of Gynecological Cancer
IF4.7
2026-04-250
PRE
Matthew L. Flint; Anna Shvygin; Paul Johannet; Seth Cohen; Jason Konner; William P. Tew; Rachel N. Grisham; Jasmine H. Francis; Julia Canestraro; Roisin E. O’Cearbhaill
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours
CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2026-01-100
OAAI
Grisham, Rachel N.; Hopp, Elizabeth; Pennington, Kathryn; Holloway, Robert; Wenham, Robert M.; Blecharz, Pawel; Dockery, Lauren; Matsuo, Koji; Salani, Ritu; Bidzinski, Mariusz; Braly, Patricia; Celano, Paul; Reid, Thomas; Seward, Shelly; Lewis, Jocelyn; Johnson, Mark; DuBose, Robert; Ahn, Sarah; Cheng, Shinta; Alvero, Carmelita; Konstantinopoulos, Panagiotis A.
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201

阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌：ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结

Future Oncology
IF2.6
2025-12-120
OAAI
Susana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer

一项关于尼洛替尼与卵巢癌新诊断患者新辅助及术后化疗联合应用的试点研究

Gynecologic Oncology
IF3.7
2025-10-310
PRE
Sara Moufarrij; Claire F. Friedman; Samuel Freeman; Hunter Green; Nadeem R. Abu-Rustum; Vance Broach; Dennis S. Chi; Seth Cohen; Ginger Gardner; Rachel N. Grisham; Alexia Iasonos; Mario M. Leitao; Kara Long; Kay Park; William Tew; Andreas Wibmer; Qin Zhou; Carol Aghajanian; Britta Weigelt; Dmitriy Zamarin; Roisin E. O'Cearbhaill
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

正在进行的基因组加倍塑造卵巢癌的进化和免疫力

Nature
IF48.5
2025-07-160
OA
Andrew McPherson; Ignacio Vázquez-García; Matthew A. Myers; Duaa H. Al-Rawi; Matthew Zatzman; Adam C. Weiner; Samuel Freeman; Neeman Mohibullah; Gryte Satas; Marc J. Williams; Nicholas Ceglia; Danguolė Norkūnaitė; Allen W. Zhang; Jun Li; Jamie L. P. Lim; Michelle Wu; Seongmin Choi; Eliyahu Havasov; Diljot Grewal; Hongyu Shi; Minsoo Kim; Roland F. Schwarz; Tom Kaufmann; Khanh Ngoc Dinh; Florian Uhlitz; Julie Tran; Yushi Wu; Ruchi Patel; Satish Ramakrishnan; DooA Kim; Justin Clarke; Hunter Green; Emily Ali; Melody DiBona; Nancy Varice; Ritika Kundra; Vance Broach; Ginger J. Gardner; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; Sarah H. Kim; Rachel N. Grisham; Ying L. Liu; Agnes Viale; Nicole Rusk; Yulia Lakhman; Lora H. Ellenson; Simon Tavaré; Samuel Aparicio; Dennis S. Chi; Carol Aghajanian; Nadeem R. Abu-Rustum; Claire F. Friedman; Dmitriy Zamarin; Britta Weigelt; Samuel F. Bakhoum; Sohrab P. Shah
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics

女性生殖道中肾样腺癌：病理诊断、临床结局及新型疗法

gynecologic oncology
IF4.1
2025-06-010
PRE
Ring, Kari L.; Mills, Anne M.; Howitt, Brooke E.; Grisham, Rachel N.; Euscher, Elizabeth D.; Kim, Hyun-Soo; Klopp, Ann H.; Kolin, David L.; McCluggage, W. Glenn; Mirkovic, Jelena; Park, Kay J.; Aoun, Eliane; Awujo, Chika; So, Ji; Mo, Samuel C.; Ferri-Borgogno, Sammy; Hong, David S.; Hoang, Lien; Jazaeri, Amir A.; How, Jeffrey A.; Lu, Karen H.
Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment

重新利用美国食品药品监督管理局批准的癌症疗法：探索低级别浆液性卵巢癌治疗中的内分泌和靶向通路

International Journal of Gynecological Cancer
IF4.7
2025-05-150
PRE
Vivek Podder; Rachel N. Grisham; Robert L. Coleman; Lauren Patterson Cobb; Bradley J. Monk; Thomas J. Herzog; David M. Gershenson; Brian M. Slomovitz
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301：一项评估阿伏莫替尼联合达法他尼与研究者选择治疗方案相比，在复发性低级别浆液性卵巢癌患者中的随机III期试验

International Journal of Gynecological Cancer
IF4.7
2025-04-190
OAAI
Rachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate

晚期卵巢癌患者接受抗FOLR1抗体药物偶联物治疗后的临床结局

gynecologic oncology
IF4.1
2025-04-010
PRE
Johannet, Paul; Flint, Matthew; Chui, M. Herman; Konner, Jason; Friedman, Claire; Green, Angela K.; Guo, Robin; Hensley, Martee L.; Kyi, Chrisann; Liu, Ying; Makker, Vicky; Rubinstein, Maria; Sabbatini, Paul; Tew, William P.; Foote, Michael B.; Weigelt, Britta; Aghajanian, Carol; Grisham, Rachel N.; O'Cearbhai, Roisin E.
Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines

卵巢癌/输卵管癌/原发性腹膜癌，版本3.2024 NCCN指南重点更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-10-0115
PRE
Liu, Joyce; Berchuck, Andrew; Backes, Floor J.; Cohen, Joshua; Grisham, Rachel; Leath, Charles A., III; Martin, Lainie; Matei, Daniela; Miller, David S.; Robertson, Sharon; Barroilhet, Lisa; Uppal, Shitanshu; Hendrickson, Andrea Wahner; Gershenson, David M.; Gray, Heidi J.; Hakam, Ardeshir; Jain, Angela; Konecny, Gottfried E.; Moroney, John; Ratner, Elena; Schorge, John; Thaker, Premal H.; Werner, Theresa L.; Zsiros, Emese; Behbakht, Kian; Chen, Lee-May; Derosa, Marie; Eisenhauer, Eric L.; Leiserowitz, Gary; Litkouhi, Babak; Mchale, Michael; Percac-Lima, Sanja; Rodabaugh, Kerry; Vargas, Roberto; Jones, Frankie; Kovach, Emily; Hang, Lisa; Ramakrishnan, Swathi; Alvarez, Ronald D.; Armstrong, Deborah K.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
NATURE MEDICINE
IF50
2024-04-234
OAAI
Friedman, Claire F.; Manning-Geist, Beryl L.; Zhou, Qin; Soumerai, Tara; Holland, Aliya; Da Cruz Paula, Arnaud; Green, Hunter; Ozsoy, Melih Arda; Iasonos, Alexia; Hollmann, Travis; Leitao, Mario M.; Mueller, Jennifer J.; Makker, Vicky; Tew, William P.; O'Cearbhaill, Roisin E.; Liu, Ying L.; Rubinstein, Maria M.; Troso-Sandoval, Tiffany; Lichtman, Stuart M.; Schram, Alison; Kyi, Chrisann; Grisham, Rachel N.; Causa Andrieu, Pamela; Wherry, E. John; Aghajanian, Carol; Weigelt, Britta; Hensley, Martee L.; Zamarin, Dmitriy
Transforming ovarian cancer care by targeting minimal residual disease

通过针对最小残留疾病转变卵巢癌护理

MED
IF11.8
2023-11-011
OAAI
Jazaeri, Amir A.; Grisham, Rachel; Knisely, Anne; Spranger, Stefani; Zamarin, Dmitriy; Hillman, R. Tyler; Lawson, Barrett C.; Burns, Kathleen H.; Lee, Sanghoon; Westin, Shannon N.; Moiso, Enrico; Williams, Marc J.; Bardhan, Neelkanth M.; Pisanic, Thomas; Matulonis, Ursula; Weigelt, Britta; Shih, Ieming; Konstantinopoulos, Panagiotis A.; Gaillard, Stephanie; Wang, Linghua; Aghajanian, Carol; D'Andrea, Alan D.; Hammond, Paula; Shah, Sohrab; Wucherpfennig, Kai W.; Lu, Karen H.
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-08-158
OAAI
Grisham, Rachel N.; Vergote, Ignace; Banerjee, Susana; Drill, Esther; Kalbacher, Elsa; Mirza, Mansoor Raza; Romero, Ignacio; Vuylsteke, Peter; Coleman, Robert L.; Hilpert, Felix; Oza, Amit M.; Westermann, Anneke; Oehler, Martin K.; Pignata, Sandro; Aghajanian, Carol; Colombo, Nicoletta; Cibula, David; Moore, Kathleen N.; del Campo, Josep M.; Berger, Regina; Marth, Christian; Sehouli, Jalid; O'Malley, David M.; Churruca, Cristina; Kristensen, Gunnar; Clamp, Andrew; Farley, John; Iyer, Gopa; Ray-Coquard, Isabelle; Monk, Bradley J.

研究方向

暂未获取到该数据
C
Carol Aghajanian
H 指数:88论文数:832被引数:3.5万
R
Roisin E. O’Cearbhaill
H 指数:38论文数:401被引数:8,102
D
Dmitriy Zamarin
H 指数:57论文数:382被引数:1.5万
M
M. Herman Chui
H 指数:22论文数:135被引数:1,599
W
William P. Tew
H 指数:55论文数:390被引数:1.5万
B
Britta Weigelt
H 指数:97论文数:1,083被引数:3.5万
C
Claire F. Friedman
H 指数:29论文数:210被引数:3,986
A
Alexia Iasonos
H 指数:61论文数:541被引数:1.5万
S
Susana Banerjee
H 指数:71论文数:667被引数:3.0万
B
Bradley J. Monk
H 指数:92论文数:1,000被引数:4.4万